Neoantigen cancer vaccine augments anti-CTLA-4 efficacy.

NPJ Vaccines · 2022 · PMC8810847 · PMID 35110563

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Analysis of granzyme b expression revealed a nonsignificant trend (Supplementary Fig. 7B ).

also in 5,406 other papers

did not reach statistical significanceno p-value reported

Neoantigen-specific T cell response was significantly increased over the control mice only in mice treated with M8/αCTLA-4, which was even more effective than the triple treatment, M8/αCTLA-4/αPD1, although it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.